China Healthcare Summit
November 2-3, 2023 | Shanghai

November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.

---

Written by Richard Daverman, PhD. Click a link below to view the mailing archive as if it had been sent to you. 2013-08-31 01:30 Siemens Shanghai Completes New Facility for X-Ray Machines 2013-08-30 01:30 J&J Names Top Executive to Lead China Operations 2013-08-29 01:30 Simcere's Go-Private Offer Price Upped Slightly; Gains Board Approval 2013-08-28 01:30 Winteam Sells its 51% Ownership in Zhongtai Biological 2013-08-27 01:30 Siegfried Holdings Building China CMO Facility and more... 2013-08-25 01:30 Week in Review: MicuRx Raises $25 Million for Antibiotic Clinical Trial 2013-08-24 01:30 Zhejiang Beta's Conmana, a Cancer Drug, is a Big Winner and more... 2013-08-23 01:30 MicuRx Raises $25 Million to Fund US-China Antibiotic Development 2013-08-22 01:30 Innovent Pharma Forms Antibody Partnership with Adimab 2013-08-21 01:30 BeiGene Signs Up Industry Veterans for Scientific Advisory Board 2013-08-20 01:30 Fosun Subsidiary to In-license Diabetes Drug from Canadian Pharma 2013-08-18 01:30 Week in Review: OrbiMed Announces $300 Million Asia Life Science Fund and more... 2013-08-17 01:30 Teva Pharma Wants to Enter China Market via Partnerships and more... 2013-08-16 01:30 Mindray Forms US Partnership with MedTest 2013-08-15 01:30 China Launches New Probe into Pharma Corruption; Novartis Accused of Bribery 2013-08-14 01:30 WuXi PharmaTech Reports Excellent Q2; Raises 2013 Guidance 2013-08-13 01:30 Cosmederm Gains CFDA Approval for Topical Skin Treatment 2013-08-11 01:30 The Week in Review: Fundings for China-Affiliated Drug Companies 2013-08-10 01:30 Whistleblower Says Sanofi Paid Kickbacks to China Doctors 2013-08-09 01:30 ScinoPharm and Sundia Form CRO Alliance in China and more... 2013-08-08 01:30 Zhongyuan Union Announces Stem Cell JV with UK Company and more... 2013-08-07 01:30 Apexigen Completes $20 Million Series A Venture Round and more... 2013-08-06 01:30 Shenogen Pharma of Beijing Raises $20 Million in C Round and more... 2013-08-04 01:30 Week in Review: China's Rx Market to Total $315 Billion in 2020 2013-08-03 01:30 Daewoong Pharma Purchases China's Liaoning Baifeng for $16 Million and more... 2013-08-02 01:30 WuXi PharmaTech-Backed Foundation Medicine Files for IPO and more... 2013-08-01 01:30 Takeda's DPP-4 Treatment for Type 2 Diabetes Approved in China and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC